Clinical trials

#AI / data analytics / healthtech / informatics #Clinical trials #Drug development #Drug discovery

AI in clinical data management: What actually works 

By Sandy Tammisetty, VP of the Veeva Services Practice Group at Conexus Solutions.  Artificial intelligence (AI) is no longer a future concept in clinical trials. It is already influencing how clinical data is reviewed, monitored, and analysed, particularly as trials become more complex and data volumes continue to grow. From anomaly detection to advanced… Read More

#Exclusive Content

FDA headquarters
#Clinical trials #MHRA #Rare disease #Regulatory #SynaptixBio

UK should offer US-style incentives in rare diseases, says biotech

The UK Medicines & Healthcare Regulatory Agency (MHRA) is consulting on a new regulatory framework for bringing rare disease drugs more quickly to market.  The new Rare Disease Therapies Regulatory Framework is intended to “support earlier, more frequent, and iterative engagement with developers, providing structured regulatory flexibility where conventional approaches… Read More

#News #Regulatory

Doctor holding x-ray
#Clinical trial design #Clinical trials #Oncology #Osteosarcoma #Paediatrics

Novel regulatory science considerations in osteosarcoma: the imperative for regulatory flexibility to meet critical unmet patient and clinical needs

Introduction Rare diseases, as classified by the FDA and EMA, are conditions that affect fewer than 200,00 people in the US1 or fewer than five in 10,000 people in the EU2. Because of these small populations, rare diseases often face unique – and some respects potentially more significant – hurdles… Read More

#Exclusive Content

FDA headquarters
#Clinical trial design #Clinical trials #FDA #Real-time clinical trials

FDA moves towards real-time clinical trials

The US Food and Drug Administration has announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT).   First, the agency unveiled the successful initiation of two proof-of-concept clinical trials that will report endpoints and data signals to the agency in real time. Read More

#Editor's Choice #News #Regulatory #Trending News

#Clinical trials #Drug discovery #MHRA #UK

UK to introduce clinical trial reforms  

New clinical trial regulations are coming into effect this week (28 April) in the UK, with the changes being the largest package of reforms in over 20 years.   Delivered by the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA), the changes will include faster assessment… Read More

#News

Clinical trial
#Clinical trials #NHS #UK government

Regulatory reforms accelerate UK clinical trial set up

NHS patients are accessing groundbreaking treatments faster as the UK government fulfils its promise for a 150-day clinical trial target.  The latest UK Clinical Research Delivery key performance indicators show the average time to set up a commercial interventional clinical trial has fallen from 169 days to 122 days when comparing the same six month period this year to last.  The improvement follows… Read More

#News #Regulatory

Clinical trial
#AI #Clinical trials #ICON

Partnership set to make therapies ‘reach patients sooner’ 

A new partnership could accelerate clinical trials and bring therapies to patients sooner.  Clinical research organisation ICON has partnered with Advarra to introduce a new ‘research-ready’ site network model for clinical trials, set to address major bottlenecks.  The partnership will integrate ICON’s global clinical trial solutions and… Read More

#News

#ABPI #Clinical trials #GLP-1 #Immune response #NHS #Obesity #Oncology #Prostate cancer #T cell #Texas A&M University Health Science Center #Weight loss

DDW Highlights: 31 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates the key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a study found obesity could be treated in other ways than through drugs… Read More

#Podcasts

#ABPI #Clinical trials #Dementia #GLP-1 #Immune response #Neuroscience #NHS #Obesity #Oncology #Prostate cancer #T cell #Texas A&M University Health Science Center #Tregs #Weight loss

This week in Drug Discovery (23 – 27 March) 

News round-up for 23 – 27 March by Bruno Quinney, Content Team at DDW.  This week, obesity could be treated in other ways than through drugs suppressing appetite. Elsewhere, prostate cancer has been a central theme in cancer research.   The top stories:    Obesity… Read More

#News

#ABPI #Clinical trial design #Clinical trials #Real world data

NHS health data should be used for clinical trial recruitment, says ABPI

The UK has an opportunity to enhance its global competitiveness in the delivery of industry clinical trials by harnessing NHS health data to more efficiently recruit patients, according to a new report from the ABPI.  Following a period of decline, the number of industry clinical trials in… Read More

#News

Microbiome
#Clinical trials #Drug discovery #Irritable Bowel Syndrome #Microbiome

EnteroBiotix announces positive results for IBS microbiome therapy  

Biopharmaceutical company EnteroBiotix has announced positive final results from its  TrIuMPH clinical trial, which is evaluating the company’s full-spectrum microbiome therapeutic for patients with irritable bowel syndrome with constipation (IBS-C) with constipation or diarrhoea (IBS-D).  The Phase IIa clinical trial included 122 UK patients and results show that EBX-102-02 demonstrated clinically meaningful improvements in the IBS symptom severity score (IBS-SSS) versus placebo. Read More

#News

Laboratory research
#Clinical trial design #Clinical trials #Medical Research Council #National Institute for Health and Care Excellence (NICE)

£50m UK centre to overhaul clinical trial design

A new UK initiative aims to shake-up approaches to clinical trial design and delivery by developing new ways to speed up the process and drive improvements.  The Medical Research Council Centre of Research Excellence in Clinical Trial Innovation in partnership with the National Institute for Health and… Read More

#News

CAR-T therapy for leukaemia
#ASH 2025 #Clinical trials #Drug discovery

CytoAgents announces positive preliminary data at ASH

Biotechnology company CytoAgents has presented preliminary safety data from its Phase Ib/IIa clinical trial of its lead drug candidate CTO1681. CTO1681 is an oral, small molecule immune modulator that uses a novel approach to prevent and mitigate both inflammation in the tumour microenvironment as well as toxicity frequently seen with… Read More

#News

Weight loss concept
#Clinical trials #Drug discovery #Obesity

Lilly begins obesity trial in the UK  

The first patient visit for Lilly’s five-year clinical trial assessing the company’s type-2 diabetes and weight-loss drug tirzepatide has taken place.  The SURMOUNT-REAL UK trial will last for five years and will assess the long-term effectiveness of tirzepatide on obesity outcomes when given in primary care settings. Taking place in Greater… Read More

#News

Vaccine
#Clinical trials #Drug development #Drug discovery #Vaccines

Developing a new targeted vaccine for Pneumococcal disease in Malawi 

Earlier this year, the Infection Innovation Consortium: iiCON and partners launched the first human challenge trial for a new vaccine for pneumococcal disease – marking a key milestone in a collaborative global project that is offering new hope in the fight against the disease. Professor Stephen Gordon, Director of Experimental… Read More

#Exclusive Content